UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)                  May 1, 2012
 
         Hydromer, Inc.
(Exact name of registrant as specified in its chapter)
 
 New Jersey
(State or other jurisdiction
of incorporation)
001-31238
(Commission
File Number)
22-2303576
(IRS Employer
Identification No.)

 

35 Industrial Parkway

Branchburg, N.J.
(Address of principal executive offices)

08876
(Zip Code)
 
   

 

Registrant's telephone number, including area code                (908) 722 – 5000  
 
 
   

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

( ) []Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

( ) []Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

( ) []Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

( ) []Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 
 

 

Item 8.01 Other Events

Press Release Announcing Hydromer’s Hydrophilic Coating used on Jotec’s EndoVascular Implant Placement Devices

 

 

EXHIBIT INDEX

Exhibit No. Description of Exhibit

 

99.44 Press Release issued April 27, 2012

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

_______Hydromer, Inc._______
Registrant

_______/s/ Robert Y. Lee_______

Date __ May 1, 2012____ Robert Y. Lee
Chief Financial Officer